Sign in

NCT07763561Not yet recruiting

EUS-DFI in Solid Pancreatic Lesions

Role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) for the Evaluation of Solid Pancreatic Tumours: A Prospective, International Multicenter Study

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Brief summary (registry, in English)

This prospective, international, multicenter observational study aims to evaluate the role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) in the characterization of solid pancreatic lesions. The study will assess microvascularization patterns identified by EUS-DFI and their association with the final diagnosis, using histopathology or clinical follow-up as the reference standard. Secondary objectives include evaluating interobserver agreement and the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant pancreatic lesions.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
48 (estimated)
First submitted
16 Jul 2026
Start date
1 Dec 2026
Primary completion date
1 Jun 2027
Lead sponsor
Julio Iglesias García
NCT number
NCT07763561

What you commit to

  • Study type: Observational
  • Planned participants: 48
  • From 1 Dec 2026 to the primary completion date, 1 Jun 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Predominantly cystic pancreatic lesions.
  • Anatomical abnormalities preventing adequate EUS examination.
  • Limited ability to understand the study procedures or provide informed consent.
  • Refusal to sign the informed consent form.

Who the study is looking for

  • Adults aged 18 years or older.
  • Presence of a solid pancreatic lesion identified during endoscopic ultrasound (EUS), regardless of the indication for the examination.
  • Ability and willingness to provide written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.